Balance Sheet

28.4B

Assets

14.4B

Liabilities

14B

Equity

Current Assets	9.5B
Cash & Short-Term Investments	1.2B
Receivables	4.3B
Other Current Assets	4B
Non-Current Assets	18.9B
Long-Term Investments	267m
PP&E	12.3B
Intangibles	4.5B
Other Non-Current Assets	1.8B

Current Liabilities	7.3B
Accounts Payable	1.6B
Other Current Liabilities	5.6B
Non-Current Liabilities	7.2B
Long-Term Debt	4.6B
Other Non-Current Liabilities	2.6B

Currency: DKK

	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	839	812	632	723	711	1 181	963	1 041	1 116
Cash Equivalents	839	812	632	723	711	1 181	963	1 041	1 116
Short-Term Investments	20	4	16	14	15	119	75	80	40
Total Receivables	3 008	3 089	2 903	3 278	3 649	3 227	3 793	4 317	4 347
Accounts Receivables	2 515	2 613	2 509	2 885	3 107	2 555	2 988	3 605	3 772
Other Receivables	493	476	394	393	542	672	805	712	575
Inventory	2 281	2 488	2 586	2 820	2 613	2 361	2 992	3 803	3 627
Other Current Assets	0	0	0	0	62	23	0	0	332
Total Current Assets	6 148	6 393	6 137	6 835	7 050	6 911	7 823	9 241	9 462
PP&E Net	8 162	8 641	8 926	9 698	10 212	9 612	10 185	12 074	12 325
PP&E Gross	8 162	8 641	8 926	9 698	10 212	9 612	10 185	12 074	12 325
Accumulated Depreciation	8 832	9 469	9 624	10 335	11 052	11 437	12 896	13 776	13 894
Intangible Assets	1 536	1 578	1 324	1 044	961	1 456	3 004	2 691	2 557
Goodwill	1 140	1 159	1 108	1 086	965	1 098	2 020	2 007	1 975
Note Receivable	116	57	35	34	29	40	39	32	43
Long-Term Investments	230	224	88	62	59	54	59	315	267
Other Long-Term Assets	459	607	755	938	1 161	1 339	1 637	1 623	1 762
Other Assets	1 140	1 159	1 108	1 086	965	1 098	2 020	2 007	1 975
Total Assets	17 791 N/A	18 659 +5%	18 373 -2%	19 697 +7%	20 437 +4%	20 510 +0%	24 767 +21%	27 983 +13%	28 391 +1%
Liabilities
Accounts Payable	1 189	1 194	1 341	1 418	1 117	1 100	1 490	1 869	1 616
Accrued Liabilities	753	712	671	723	748	583	685	693	820
Short-Term Debt	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	74	89	971	1 789	1 543	1 242	2 151	2 941	3 172
Other Current Liabilities	1 284	1 567	1 594	1 595	1 327	1 236	1 347	1 460	1 654
Total Current Liabilities	3 300	3 562	4 577	5 525	4 735	4 161	5 673	6 963	7 262
Long-Term Debt	1 202	1 714	1 303	1 469	3 159	3 630	4 037	3 907	4 561
Deferred Income Tax	715	854	721	892	879	1 204	1 337	1 653	1 965
Minority Interest	13	13	13	13	12	11	379	391	373
Other Liabilities	981	784	505	373	184	271	1 514	1 232	252
Total Liabilities	6 211 N/A	6 927 +12%	7 119 +3%	8 272 +16%	8 969 +8%	9 277 +3%	12 940 +39%	14 146 +9%	14 413 +2%
Equity
Common Stock	626	620	610	594	582	570	564	562	562
Retained Earnings	10 396	10 483	10 861	10 943	10 810	11 263	11 303	13 062	13 755
Other Equity	558	629	217	112	76	600	40	213	339
Total Equity	11 580 N/A	11 732 +1%	11 254 -4%	11 425 +2%	11 468 +0%	11 233 -2%	11 827 +5%	13 837 +17%	13 978 +1%
Total Liabilities & Equity	17 791 N/A	18 659 +5%	18 373 -2%	19 697 +7%	20 437 +4%	20 510 +0%	24 767 +21%	27 983 +13%	28 391 +1%
Shares Outstanding
Common Shares Outstanding	303	298	293	288	281	279	277	277	277

Income Statement Balance Sheet Cash Flow Statement

Novozymes A/S
CSE:NZYM B

Balance Sheet

Balance Sheet Decomposition
Novozymes A/S

Balance Sheet
Novozymes A/S

See Also

Company

Help

Tools

Stocks

Novozymes A/S CSE:NZYM B

Balance Sheet

Balance Sheet Decomposition Novozymes A/S

Balance Sheet Novozymes A/S

See Also

Company

Help

Tools

Stocks

Novozymes A/S
CSE:NZYM B

Balance Sheet Decomposition
Novozymes A/S

Balance Sheet
Novozymes A/S